Second Circuit Rules in Favor of Williams & Connolly Client Hospira

October 2020

On October 26, 2020, the Second Circuit affirmed a decision by the SDNY in favor of Pfizer subsidiary Hospira in a commercial dispute brought against Hospira by Apotex Corp. In 2019, the trial court granted Hospira’s motion to dismiss various tort claims and accompanying damages theories, a decision now affirmed by the Second Circuit; and in January 2020, the trial court granted Hospira’s motion to dismiss Apotex’s antitrust claims, a decision Apotex did not appeal. With these wins, the dispute is narrowed to a few state law claims in state court in New York. Luke McCloud of Williams & Connolly argued before the Second Circuit; the Williams & Connolly team also included associates Paul Ream and Wendy Zupac, as well as partners Ana Reyes and Heidi Hubbard.

Click here to read coverage from Law360.
 

Benchmark Litigation Names Five Partners Among “Top 250 Women in Litigation”

Benchmark Litigation Names Five Partners Among “Top 250 Women in Litigation”
back to top